Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Quality Index of 2.32x as of June 2023. Operating cash flow of €2.10 Billion exceeds net income of €902.65 Million, indicating high earnings quality where cash backs reported profits. Explore Guangzhou Baiyunshan Pharmaceutical Hold cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Guangzhou Baiyunshan Pharmaceutical Hold (GU5) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Year-by-year earnings quality comparison for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For live market cap and the full company financial profile, see GU5 market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | €-232.46 Million | €2.98 Billion | ▼ -106.4% |
| 2024 | 1.21x | €3.44 Billion | €2.84 Billion | ▲ +20.0% |
| 2023 | 1.01x | €4.10 Billion | €4.06 Billion | ▼ -42.7% |
| 2022 | 1.76x | €7.00 Billion | €3.97 Billion | ▲ +15.7% |
| 2021 | 1.53x | €5.67 Billion | €3.72 Billion | ▲ +659.8% |
| 2020 | 0.20x | €585.19 Million | €2.92 Billion | ▼ -87.3% |
| 2019 | 1.57x | €5.02 Billion | €3.19 Billion | ▲ +3.9% |
| 2018 | 1.52x | €5.22 Billion | €3.44 Billion | ▲ +70.5% |
| 2017 | 0.89x | €1.83 Billion | €2.06 Billion | ▼ -47.3% |
| 2016 | 1.69x | €2.54 Billion | €1.51 Billion | ▲ +13.0% |
| 2015 | 1.49x | €1.94 Billion | €1.30 Billion | ▲ +2.0% |
| 2014 | 1.46x | €1.75 Billion | €1.19 Billion | ▲ +7.4% |
| 2013 | 1.36x | €1.34 Billion | €980.05 Million | — |